Top upgrades and downgrades on 4/1

Analysts Notebook wrote a column · Apr 1, 2022 18:53

Upgrades

• $Centennial Resource Development (CDEV.US)$ : Stifel Upgrades to Buy from Hold - PT $11.20 (from $8.40)

• $Comerica (CMA.US)$ : Goldman Sachs Upgrades to Buy from Sell - PT $112 (from $102)

• $Comerica (CMA.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $115 (from $108)

• $Five Below (FIVE.US)$ : Citigroup Upgrades to Buy From Neutral

• $Tellurian (TELL.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $8 (from $5.50)

• $Vertiv Holdings (VRT.US)$ : JP Morgan Upgrades to Overweight From Neutral - PT $18 (from $29)

• $Wynn Resorts (WYNN.US)$ : Citigroup Upgrades to Buy from Neutral - PT $96.50 (from $98)

Downgrades

• $American Eagle (AEO.US)$ : Barclays Downgrades to Equalweight from Overweight - PT $19 (from $24)

• $Amylyx Pharmaceuticals (AMLX.US)$ : Goldman Sachs Downgrades to Neutral from Buy - PT $10

• $BankUnited (BKU.US)$ : JPMorgan Downgrades to Neutral from Overweight - PT $50

• $Blend Labs (BLND.US)$ : Canaccord Genuity Downgrades to Hold from Buy - PT $5 (from $28)

• $CommScope (COMM.US)$ : Goldman Sachs Downgrades to Neutral from Buy - PT $9

• $Dell Technologies (DELL.US)$ : Goldman Sachs Downgrades to Neutral from Buy - PT $61

• $Ellington Credit (EARN.US)$ : JMP Securities Downgrades to Market Perform from Market Outperform

• $First American Financial (FAF.US)$ : Credit Suisse Downgrades to Neutral From Outperform - PT $74 (From $97)

• $Gap Inc (GPS.US)$ : Barclays Downgrades to Underweight from Equalweight - PT $13 (from $17)

• $NextDecade (NEXT.US)$ : Credit Suisse Downgrades to Neutral From Outperform - PT $7.5 (From $3)

• $Orchard Therapeutics (ORTX.US)$ : SMBC Nikko Securities Downgrades to Neutral from Outperform

• $Poshmark (POSH.US)$ : Stifel Downgrades to Hold from Buy - PT $15 (from $19)

• $Qorvo (QRVO.US)$ : KGI Securities Downgrades to Neutral from Outperform - PT $140

• $Science Applications International (SAIC.US)$ : Truist Securities Downgrades to Hold from Buy - PT $105

• $UniFirst (UNF.US)$ : JPMorgan Downgrades to Underweight from Neutral - PT $178 (from $200)

• $Wayfair (W.US)$ : Barclays Downgrades to Underweight from Equal Weight - PT $103 (from $123)

• $Walgreens Boots Alliance (WBA.US)$ : Baird Downgrades to Neutral from Outperform - PT $51

• $Zimmer Biomet Holdings (ZBH.US)$ : Citigroup Downgrades to Neutral from Buy - PT $129 (from $125)

Initiated

• $Agree Realty Corp (ADC.US)$ : Morgan Stanley initiates at Overweight - PT $75

• $Check Point Software (CHKP.US)$ : Summit Insights initiates at Buy - PT $160

• $Immuneering (IMRX.US)$ : Oppenheimer initiates at Outperform - PT $25

• $MSCI Inc (MSCI.US)$ : Goldman Sachs initiates at Neutral - PT $553

• $Oracle (ORCL.US)$ : Daiwa Securities initiates at Neutral - PT $87

• $Rain Oncology (RAIN.US)$ : Oppenheimer initiates at Outperform - PT $15

• $Upstart (UPST.US)$ : Stephens initiates at Equal Weight - PT $124

• $Vectrus (VEC.US)$ : Truist Securities initiates at Buy - PT $65

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

493K Views

Comment

BullRunner : Thanks for the heads-up! I find it to be very informative.

Report
Reply

Cancel Reply
Tyler Moo :

Report
Reply

Cancel Reply
Golden brown sacks : My wife want to invest and her we are

Report
Reply

Cancel Reply

Analysts Notebook

Moomoo News Official Account

How do analysts evaluate the market?

19K

Followers

Following

39K

Visitors